Patents by Inventor Edward F. Elslager

Edward F. Elslager has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5620997
    Abstract: Isothiazolones having the general structure ##STR1## where A is a monocyclic or bicyclic ring which may contain up to 3 heteroatoms selected from O, S, and N; R.sup.1 and R.sup.2 are substituent groups such as alkyl, alkoxy, hydroxy, nitro, cyano, amino, and carboxy; and R.sup.5 is alkyl, cycloalkyl, phenyl, and Het. The isothiazolones are useful as anti-retroviral agents, anti-inflammatory agents, and anti-atherosclerotic agents.
    Type: Grant
    Filed: May 31, 1995
    Date of Patent: April 15, 1997
    Assignee: Warner-Lambert Company
    Inventors: Gary L. Bolton, John M. Domagala, Edward F. Elslager, Rocco D. Gogliotti, Terri S. Purchase, Joseph P. Sanchez, Bharat K. Trivedi
  • Patent number: 5463122
    Abstract: Antibacterial and antiviral phenylthiols and dithiobisbenzamides have the formula ##STR1## where n is 1 or 2, Y is hydrogen when n is 1, and a single bond when n is 2; and R.sup.1 and R.sup.11 are substituent groups, R.sup.4 is hydrogen or alkyl, and Z is hydrogen, alkyl, cycloalkyl or sulfamoylphenyl.
    Type: Grant
    Filed: August 5, 1994
    Date of Patent: October 31, 1995
    Assignee: Warner-Lambert Company
    Inventors: Edward F. Elslager, Rocco D. Gogliotti
  • Patent number: 4853221
    Abstract: 5-Methyl-6-[[(3,4,5-trimethoxyphenyl)amino]-methyl]-2,4-quinazolinediamine (trimetrexate) has been shown to possess clinical activity against non-small cell lung cancer, head and neck squamous cancers, and breast cancer. The compound also demonstrates therapeutic synergy with several known antineoplastic agents. Methods of treating non-small cell lung cancer, head and neck cancers, and breast cancer by administering trimetrexate alone or in combination with other neoplastic agents is disclosed.
    Type: Grant
    Filed: October 23, 1987
    Date of Patent: August 1, 1989
    Assignee: Warner-Lambert Company
    Inventors: Edward F. Elslager, Wilbur R. Leopold, III
  • Patent number: 4657909
    Abstract: Acids, esters, imine acids, imine esters, and imine amides derived from 6-formyl-4,7,9-trihydroxy-1-phenazinecarboxylic acid, methyl ester and from 6-formyl-4,7,9-trihydroxy-8-methyl-1-phenazinecarboxylic acid, methyl ester demonstrate antimicrobial and antineoplastic activity.A purified strain of Streptomyces galanosa, NRRL 15738, is capable of producing 6-formyl-4,7,9-trihydroxy-8-methyl-1-phenazinecarboxylic acid, methyl ester in isolable quantities from a fermentation broth containing assimilable sources of carbon and nitrogen.
    Type: Grant
    Filed: June 10, 1985
    Date of Patent: April 14, 1987
    Assignee: Warner-Lambert Company
    Inventors: Christopher F. Bigge, Edward F. Elslager, James C. French, Blanche D. Graham, Gerard C. Hokanson, Stephen W. Mamber, Tim A. Smitka, Josefino B. Tunac, John H. Wilton
  • Patent number: 4604390
    Abstract: Substituted 2H-[1]benzopyrano[4,3,2-cd]indazoles, 2H-[1]benzothiopyrano[4,3,2-cd]indazoles, and 2H-[1]benzoselenino[4,3,2-cd]indazoles have demonstrated pharmacological activity against a broad spectrum of Gram-positive and Gram-negative bacteria, yeasts, and fungi, as well as activity against the L1210 and P388 murine leukemia cells lines.Pharmaceutical compositions containing the compounds and methods of employing the compounds in methods of treating bacterial or fungal infections and of inhibiting the growth of neoplasms in mammals are also disclosed.
    Type: Grant
    Filed: May 24, 1985
    Date of Patent: August 5, 1986
    Assignee: Warner-Lambert Company
    Inventors: Edward F. Elslager, Leslie M. Werbel, Daniel F. Ortwine, Donald F. Worth, Howard D. H. Showalter, David B. Capps, Ellen M. Berman, Vlad E. Gregor, Anthony D. Sercel
  • Patent number: 4556654
    Abstract: Substituted anthra[1,9-cd]pyrazol-6(2H-ones have antimicrobial activity. Methods for their preparation, use and pharmaceutical compositions are disclosed.
    Type: Grant
    Filed: June 28, 1983
    Date of Patent: December 3, 1985
    Assignee: Warner-Lambert Company
    Inventors: Howard D. H. Showalter, Judith L. Johnson, Leslie M. Werbel, Edward F. Elslager
  • Patent number: 4505925
    Abstract: The title compositions containing N,N-diethyl-5-methyl-2H-12-benzothiopyrano-4,3,2-cd-indazole-2-ethanamine as the free base (I) or pharmaceutically acceptable acid addition salt, and methods for their use are provided. The compositions are useful for treating tumors in warm blooded animals.
    Type: Grant
    Filed: May 20, 1983
    Date of Patent: March 19, 1985
    Assignee: Warner-Lambert Company
    Inventors: Edward F. Elslager, Leslie M. Werbel
  • Patent number: 4391809
    Abstract: Methods for treating psoriasis by administering 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]-quinazoline, 2,4-diamino-5-chloro-6-[(3,4-dichloroanilino)methyl]-quinazoline or a pharmaceutically acceptable acid-addition salt thereof.
    Type: Grant
    Filed: November 13, 1980
    Date of Patent: July 5, 1983
    Assignee: Warner-Lambert Company
    Inventor: Edward F. Elslager